Latest Us Markets News

Cleo Diagnostics has begun developing a multi-biomarker blood test for ovarian cancer screening in asymptomatic women, targeting a stated $150 billion global market. The prototype program will run alongside the company’s pre-surgical test, with initial proof-of-concept data expected early next quarter.

Latrobe Magnesium has received a non-binding US$15 million Letter of Support from a confidential US financial institution for the feasibility study on its proposed 50 ktpa South Carolina magnesium plant. The funding remains conditional on matching finance, due diligence, approvals and definitive agreements.

Latrobe Magnesium is shifting its growth priority to a proposed 50 ktpa magnesium plant in South Carolina, backed by 32 ktpa of non-binding customer interest and a 20-year feedstock agreement. The project carries substantial indicative economics, but still needs funding, site acquisition, feasibility work, permits and binding offtake contracts.

Resolution Minerals has finished its largest-ever exploration program at the Horse Heaven project in Idaho, drilling 42 diamond holes across 12,236 metres. The work sets up a substantial run of gold, tungsten and multi-element assay results, but the completed program has not yet produced new assay data in this announcement.

Emyria has secured a limited in-person speaking position at a US FDA hearing examining how psychedelic medicines could be delivered safely and at scale. The appearance gives the ASX-listed company a regulatory platform, but does not represent FDA approval, funding or a commercial agreement.

Elixinol Wellness has finalized the divestment of its US operations to Ananda Health, securing upfront and deferred payments totaling approximately A$465,000. This move refocuses the company on its Australian health and wellness portfolio while reducing exposure to US regulatory risks.

EBR Systems has secured ISO 13485 certification for its new Santa Clara manufacturing site, paving the way for a 500% increase in WiSE System production pending FDA approval expected by year-end.

OD6 Metals has significantly increased the Mammoth fluorspar target footprint at its Quinn Project in Nevada, revealing broad, high-grade mineralisation with assays up to 85.9% CaF2 and preparing for drilling to define the system's scale.

Savana US Small Caps Active ETF (ASX:SVNP) reversed last year’s loss to deliver a AUD 1.37 million profit for FY 2026, lifting net assets to AUD 5.94 million amid steady investor inflows and solid US small cap equity performance.

Immuron Limited has inked an exclusive US distribution deal for PROIBS®, a European-certified medical device targeting abdominal discomfort, marking a key step in its digestive health portfolio growth.

Everest Metals has appointed Hall Chadwick as exclusive strategic adviser to explore funding and commercial pathways for its Mt Edon rubidium project, focusing on US and allied market opportunities.

Ionic Rare Earths (ASX: IXR) and US Strategic Metals have agreed to a 50-50 joint venture to develop rare earth magnet recycling facilities at a fully permitted Missouri site, backed by US$100 million in funding.